Dr Hrach Ike Kasaryan, DO | |
400 Frank W Burr Blvd, #22, Second Floor, Teaneck, NJ 07666-6839 | |
(201) 928-2300 | |
(201) 692-3263 |
Full Name | Dr Hrach Ike Kasaryan |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 20 Years |
Location | 400 Frank W Burr Blvd, Teaneck, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023296936 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Hackensack, NJ | Home health agency |
Holy Name Home Care | Teaneck, NJ | Home health agency |
Valley Home Care Inc. | Paramus, NJ | Home health agency |
Visiting Health Services Of New Jersey | Totowa, NJ | Home health agency |
Hackensack University Medical Center | Hackensack, NJ | Hospital |
Holy Name Medical Center | Teaneck, NJ | Hospital |
Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
Hackensack Meridian Health Pascack Valley Medical | Westwood, NJ | Hospital |
Palisades Medical Center | North bergen, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
Mpv New Jersey Md Services Pc | 5991097669 | 120 |
News Archive
Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, "Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors," was published in the latest issue of the journal Diabetologia.
The U.S. House of Representatives today passed H.R. 3663, a bill introduced yesterday by Reps. Zach Space (D-OH) and Lee Terry (R-NE) extending the accreditation deadline for pharmacies providing Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) from Sept. 30 to Dec. 31, 2009.
› Verified 2 days ago
Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, "Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors," was published in the latest issue of the journal Diabetologia.
The U.S. House of Representatives today passed H.R. 3663, a bill introduced yesterday by Reps. Zach Space (D-OH) and Lee Terry (R-NE) extending the accreditation deadline for pharmacies providing Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) from Sept. 30 to Dec. 31, 2009.
› Verified 2 days ago
Entity Name | Humc Cardiovascular Partners, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417188905 PECOS PAC ID: 6406996503 Enrollment ID: O20091222000199 |
News Archive
Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, "Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors," was published in the latest issue of the journal Diabetologia.
The U.S. House of Representatives today passed H.R. 3663, a bill introduced yesterday by Reps. Zach Space (D-OH) and Lee Terry (R-NE) extending the accreditation deadline for pharmacies providing Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) from Sept. 30 to Dec. 31, 2009.
› Verified 2 days ago
Entity Name | Mpv New Jersey Md Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215391271 PECOS PAC ID: 5991097669 Enrollment ID: O20160718000760 |
News Archive
Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, "Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors," was published in the latest issue of the journal Diabetologia.
The U.S. House of Representatives today passed H.R. 3663, a bill introduced yesterday by Reps. Zach Space (D-OH) and Lee Terry (R-NE) extending the accreditation deadline for pharmacies providing Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) from Sept. 30 to Dec. 31, 2009.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Hrach Ike Kasaryan, DO 400 Frank W Burr Blvd, # 22, Second Floor, Teaneck, NJ 07666-6839 Ph: (201) 928-2300 | Dr Hrach Ike Kasaryan, DO 400 Frank W Burr Blvd, #22, Second Floor, Teaneck, NJ 07666-6839 Ph: (201) 928-2300 |
News Archive
Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, "Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors," was published in the latest issue of the journal Diabetologia.
The U.S. House of Representatives today passed H.R. 3663, a bill introduced yesterday by Reps. Zach Space (D-OH) and Lee Terry (R-NE) extending the accreditation deadline for pharmacies providing Medicare Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) from Sept. 30 to Dec. 31, 2009.
› Verified 2 days ago
Dr. David Marc Wild, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 954 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-2300 Fax: 201-833-7600 | |
Joseph Frascino, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3258 Fax: 201-833-3260 | |
Judy Mei-chia Lin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1086 Teaneck Rd Ste 4c, Teaneck, NJ 07666 Phone: 201-837-9449 Fax: 201-578-1699 | |
Dr. Ralph E Marcus, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 Queen Anne Rd, Teaneck, NJ 07666 Phone: 201-837-7788 Fax: 201-837-2077 | |
Mrs. Sarwat W Umer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Cedar Ln, Teaneck, NJ 07666 Phone: 201-836-4248 Fax: 201-836-5420 | |
Dr. Erina Khadka Kunwar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 185 Cedar Ln Ste U7, Teaneck, NJ 07666 Phone: 201-300-2768 |